Coagulation factor X
Jeneng umum: Coagulation Factor X
Jeneng merek: Coagadex
Bentuk dosis: bubuk intravena kanggo injeksi (-)
Kelas obat:
Aneka modifikasi koagulasi
Panganggone Coagulation factor X
Faktor koagulasi X (10) ya iku protèin gawéan manungsa sing padha karo protèin alami ing awak sing mbantu getih dadi beku.
Faktor koagulasi X digunakake kanggo nambani utawa nyegah pendarahan ing wong sing kekurangan faktor keturunan X. Obat iki digunakake kanggo wong diwasa lan bocah.
Faktor koagulasi X uga bisa digunakake kanggo tujuan sing ora kadhaptar ing pandhuan pengobatan iki.
Coagulation factor X efek sisih
Njaluk bantuan medis darurat yen sampeyan duwe tandha reaksi alergi: gatal-gatal, gatal, tingling; wheezing, sesak ing dada, ambegan angel; deg-degan cepet; kroso kaya sampeyan bisa mati; bengkak ing rai, lambe, ilat, utawa tenggorokan.
Faktor koagulasi X bisa nyebabake efek samping sing serius. Langsung hubungi dhokter yen sampeyan duwe:
mriyang utawa hawa adhem, watuk, lara awak, kurang tenaga;
Efek sisih umum saka faktor koagulasi X bisa kalebu: b>
Iki dudu dhaptar lengkap efek samping lan liya-liyane. bisa kedadeyan. Telpon dhokter kanggo saran medis babagan efek samping. Sampeyan bisa nglaporake efek samping menyang FDA ing 1-800-FDA-1088.
Sadurunge njupuk Coagulation factor X
Sampeyan ora kudu nggunakake faktor koagulasi X yen sampeyan duwe reaksi alergi marang obat faktor pembekuan.
Aja menehi obat iki marang bocah tanpa saran medis.
Marang dhokter yen sampeyan lagi ngandhut utawa nyusoni.
Faktor koagulasi X digawe saka plasma manungsa sing disumbang lan bisa ngemot virus utawa agen infèksi liyane. Plasma sing disumbang diuji lan diobati kanggo nyuda risiko kontaminasi, nanging isih ana kemungkinan cilik bisa nularake penyakit. Takon dhokter sampeyan babagan risiko apa wae.
Related obat
- Advate
- Adynovate
- Adynovate recombinant
- Afstyla
- Afstyla recombinant
- Agrylin
- Alphanate
- Alphanine SD
- Alprolix
- Alprolix (Factor ix fc fusion protein recombinant Intravenous)
- Altuviiio
- Altuviiio (Antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl Intravenous)
- Altuviiio (Antihemophilic factor Intravenous)
- Amicar
- Amicar (Aminocaproic acid Intravenous)
- Amicar (Aminocaproic acid Oral)
- Aminocaproic acid
- Aminocaproic acid (Intravenous)
- Aminocaproic acid (Oral)
- Anagrelide
- Anti-inhibitor coagulant complex
- Antihemophilic and von Willebrand factor complex
- Antihemophilic factor
- Antihemophilic factor (recombinant) pegylated-aucl
- Antihemophilic factor (recombinant) porcine sequence
- Antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl
- Antihemophilic factor (recombinant), glycopegylated-exei
- Antihemophilic factor human
- Antihemophilic factor recombinant
- Antihemophilic factor viii and von willebrand factor
- Artiss
- Artiss Duo Set
- Artiss Duploject
- Autoplex T
- Coagadex
- Coagulation factor IX
- Coagulation factor ix recombinant
- Coagulation factor ix recombinant, glycopegylated
- Coagulation factor viia
- Coagulation factor VIIa injection
- Coagulation factor viia-jncw
- Coagulation factor X
- Corifact
- Cyklokapron
- Bebulin VH
- BeneFIX
- Benefix (Coagulation factor ix recombinant Intravenous)
- Ceprotin
- Defibrotide
- Defitelio
- Eloctate
- Eloctate with Fc Fusion Protein recombinant
- Emicizumab
- Emicizumab-kxwh
- Esperoct (Antihemophilic factor (recombinant), glycopegylated-exei Intravenous)
- Esperoct (Antihemophilic factor Intravenous)
- Esperoct recombinant
- Evarrest
- Factor ix albumin fusion protein recombinant
- Factor IX complex
- Factor ix fc fusion protein recombinant
- Factor x human
- Factor XIII
- Feiba VH Immuno
- Feiba-VH
- Fibrin sealant topical
- Fibrinogen
- Fibrinogen and thrombin, human
- Fibrinogen/aprotinin and thrombin/calcium chloride
- Fostamatinib
- Fostamatinib disodium
- Helixate FS
- Helixate FS recombinant
- Hemlibra
- Hemofil-M
- Hemofil-M human
- Humate-P
- Hyate:C
- Idelvion
- Idelvion (Factor ix albumin fusion protein recombinant Intravenous)
- Ixinity
- Ixinity (Coagulation factor ix recombinant Intravenous)
- Jivi (Antihemophilic factor (recombinant) pegylated-aucl Intravenous)
- Jivi (Antihemophilic factor Intravenous)
- Jivi recombinant
- Koate DVI
- Koate-DVI human
- Kogenate FS
- Kogenate FS recombinant
- Kogenate FS with Adapter recombinant
- Kovaltry recombinant
- Lysteda
- Monoclate-P human
- Mononine
- Novoeight recombinant
- Novoseven
- NovoSeven RT
- NovoSeven RT with MixPro injection
- Nuwiq recombinant
- Obizur (Antihemophilic factor (recombinant) porcine sequence Intravenous)
- Obizur (Antihemophilic factor Intravenous)
- Pentopak
- Pentoxifylline
- Pentoxil
- Protein c, human
- Raplixa
- Rebinyn
- Rebinyn (Coagulation factor ix recombinant, glycopegylated Intravenous)
- Recombinate recombinant
- RiaSTAP
- Rixubis
- Rixubis (Coagulation factor ix recombinant Intravenous)
- Roctavian
- Tachosil
- Tavalisse
- Thrombin human, recombinant
- Tisseel
- Tisseel Duploject Kit
- Tisseel Valupak Kit
- Tranexamic acid
- Tranexamic acid (Intravenous)
- Tranexamic acid (Oral)
- Tranexamic acid Lysteda
- Trental
- Tretten
- Valoctocogene roxaparvovec-rvox
- Von Willebrand factor recombinant
- Vonvendi
- Wilate
- Xyntha
Carane nggunakake Coagulation factor X
Dosis Dewasa Biasa kanggo Kekurangan Faktor X:
Pengobatan lan Kontrol On-demand:25 unit internasional/kg IV infus ing tandha pisanan pendarahan; baleni saben 24 jam nganti getihen mandheg. Dosis maksimal: 60 unit internasional / kg / dina. = bobot awak [kg] x sing dikarepake Faktor X mundhak [unit internasional/dL] x 0,5). Pasca-bedah:-Baleni dosis pra-bedah yen perlu kanggo njaga tingkat Faktor X ing minimal 50 unit internasional/dL nganti pasien wis ora ana risiko pendarahan maneh amarga operasi. Dosis maksimal: 60 unit internasional / kg / dinaKomentar: Ukur tingkat Faktor X pasca infus sadurunge lan sawise operasi. Panganggone: Manajemen pendarahan perioperatif ing pasien kanthi kekurangan Faktor X turun temurun sing entheng.
Dosis Pediatrik Biasa kanggo Kekurangan Faktor X:
12 TAHUN UTAWA: Perawatan lan Kontrol On-demand: 25 unit internasional / kg infus IV ing tandha pisanan getihen; baleni saben 24 jam nganti getihen mandheg. Dosis maksimal: 60 unit internasional / kg / dina. = bobot awak [kg] x sing dikarepake Faktor X mundhak [unit internasional/dL] x 0,5). Pasca-bedah:-Baleni dosis pra-bedah yen perlu kanggo njaga tingkat Faktor X ing minimal 50 unit internasional/dL nganti pasien wis ora ana risiko pendarahan maneh amarga operasi. Dosis maksimal: 60 unit internasional / kg / dinaKomentar: Ukur tingkat Faktor X pasca infus sadurunge lan sawise operasi. Panganggone: Manajemen pendarahan perioperatif ing pasien kanthi kekurangan Faktor X turun temurun sing entheng.
Pènget
Tututi kabeh pituduh ing label lan paket obat sampeyan. Marang saben panyedhiya kesehatan babagan kabeh kondisi medis, alergi, lan kabeh obat sing sampeyan gunakake.
Apa obatan liyane bakal mengaruhi Coagulation factor X
Obat liyane bisa mengaruhi faktor koagulasi X, kalebu resep lan obat-obatan sing ora bisa dituku, vitamin, lan produk herbal. Marang dhokter sampeyan babagan kabeh obat sing saiki lan obat apa wae sing sampeyan wiwiti utawa mandheg nggunakake.
Disclaimer
Kabeh upaya wis ditindakake kanggo mesthekake yen informasi sing diwenehake dening Drugslib.com akurat, nganti -tanggal, lan lengkap, nanging ora njamin kanggo efek sing. Informasi obat sing ana ing kene bisa uga sensitif wektu. Informasi Drugslib.com wis diklumpukake kanggo digunakake dening praktisi kesehatan lan konsumen ing Amerika Serikat lan mulane Drugslib.com ora njamin sing nggunakake njaba Amerika Serikat cocok, kajaba khusus dituduhake digunakake. Informasi obat Drugslib.com ora nyetujoni obat, diagnosa pasien utawa menehi rekomendasi terapi. Informasi obat Drugslib.com minangka sumber informasi sing dirancang kanggo mbantu praktisi kesehatan sing dilisensi kanggo ngrawat pasien lan / utawa nglayani konsumen sing ndeleng layanan iki minangka tambahan, lan dudu pengganti, keahlian, katrampilan, kawruh lan pertimbangan babagan perawatan kesehatan. praktisi.
Ora ana bebaya kanggo kombinasi obat utawa obat sing diwenehake kanthi cara apa wae kudu ditafsirake kanggo nuduhake yen obat utawa kombinasi obat kasebut aman, efektif utawa cocok kanggo pasien tartamtu. Drugslib.com ora nanggung tanggung jawab kanggo aspek kesehatan apa wae sing ditindakake kanthi bantuan informasi sing diwenehake Drugslib.com. Informasi sing ana ing kene ora dimaksudake kanggo nyakup kabeh panggunaan, pituduh, pancegahan, bebaya, interaksi obat, reaksi alergi, utawa efek samping. Yen sampeyan duwe pitakon babagan obat sing sampeyan gunakake, takon dhokter, perawat utawa apoteker.
Tembung kunci populer
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions